Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): Frequent expression of CD56 and interleukin-2 receptor α chain

Abstract

We report the cellular characteristics of cells from three patients with de novo acute myelocytic leukaemia (AML) with t(16;21)(p11;q22), two M4 and one M5a according to the FAB classification, and two permanent cell lines with t(16;21)(p11;q22), TSU1621MT and YNH-1. The FUS/ERG fusion mRNA was demonstrated in all cases by reverse transcriptase-polymerase chain reaction (RT-PCR). The immunophenotypes of the AML cells, and YNH-1 and TSU1621MT cell lines with t(16;21) were characterized as CD34+CD33+CD13+CD11b+CD18+CD56+ HLA-DR(-/+). Cells from all samples strongly expressed c-kit, granulocyte colony-stimulating factor receptor (G- CSFR), c-fms (macrophage colony-stimulating factor receptor), interleukin-3 receptor ∅ chain (IL-3Rα), and granulocyte macrophage colony-stimulating factor receptor α chain (GM-CSFRα), and these data corresponded well to the growth responsiveness to the cytokines. IL-2Rα expression was also found in all t(16;21) samples, but IL-2 did not act on the proliferation of the leukaemic cells in in vitro cultures. G-CSF distinctly promoted the proliferation of leukaemic cells of t(16;21) AML, but did not enhance the expression of MPO and neutrophil differentiation of these cells. Our findings indicate that AML cells with t(16;21) preserve stem cell properties such as CD34 and c-kit expression, and suggest that they have the potential to differentiate into a monocytic lineage. The relationship between the unique cellular characteristics (especially CD56 and IL-2Rα expression) and FUS/ERG protein remains undetermined.